AONC American Oncology Network Bozor kapitallashuvining balans qiymatiga nisbati

aoncology.com (AONC) korporativ emblemasi va logotipi

Kirish uchun yuqori to'siqlar va davlat tartibga solish choralari oligopoliyani yaratadi, bu esa bozor kapitalizatsiyasining kitob qiymatidan yuqori bo'lgan premiumini barqarorlashtiradi; GURU.Markets grafiklarini tahlil qilib, biz -0.19 joriy metrika qiymati ekanligini aniqladik. American Oncology Network (AONC) fundamental ko'rsatkichlari uning klinika tarmog'ining benuqson obro'siga va onkologiyaning defensiv tabiatiga tayanadi, bunda talab YaIM tebranishlari va xonadonlar daromadidan mustaqil qoladi.

American Oncology Network, Inc. (AONC) - Bozor kapitallashuvining balans qiymatiga nisbati 21.02.2024dan 04.08.2024gacha
American Oncology Network yetakchi tovari

Ushbu koeffitsient kelajakdagi o'sish uchun premiumni aniqlash maqsadida American Oncology Network (AONC) kompaniyasining joriy bozor qiymatini uning sof aktivlari bilan solishtiradi. Kompaniya qiymatini balans hisoboti bilan nisbatan tahlil qilish orqali investor onkologik terapiyaga bo'lgan talab ortayotgan bir paytda American Oncology Network (AONC) klinikalarining operatsion samaradorligini baholaydi. Ushbu ko'rsatkich ambulator yordam tarmog'ining kengayish imkoniyatlariga bozorning ishonchini aks ettiradi. Ushbu nisbatning barqarorligi biznesning fundamental chidamliligini tasdiqlaydi. Mazkur ko'rsatkichning tendentsiyasi aktivlarning ob'ektiv qiymati va spekulyativ kutishlar o'rtasidagi farqni ajratish imkonini beradi.

American Oncology Network kimlar bilan raqobatlashadi

ONC: Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati halozyme.com|RVMD (Revolution Medicines, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Ascentage Pharma Group International (AAPG)|Bozor kapitallashuvining balans qiymatiga nisbati CGON|Bozor kapitallashuvining balans qiymatiga nisbati UroGen Pharma Corp (URGN)|Bozor qiymatining balans qiymatiga nisbati Bicara Therapeutics Inc. BCAX|PSNL: Kapitallashuvning balans qiymatiga nisbati|Erasca - Bozor kapitallashuvining balans qiymatiga nisbati|Delcath Systems Inc (DCTH) - Kapitallashuvning sof aktivlarga nisbati|YMAB: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Aura Corp (AURA)|Bozor qiymatining balans qiymatiga nisbati Candel Therapeutics Inc.|ARAY: Balans qiymatiga nisbatan bozor qiymati|Kapitallashuvning sof aktivlarga nisbati SLS (SELLAS Life Sciences)|ACTU (Actuate Therapeutics Inc.) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati CTOR (Citius Oncology, Inc)|HURA - Kapitallashuvning sof aktivlarga nisbati|TARA: Kapitallashuvning sof aktivlarga nisbati|FATE - Bozor kapitallashuvining balans qiymatiga nisbati|aadibio.com (WHWK) - Bozor qiymatining balans qiymatiga nisbati|TScan Therapeutics, Inc. - Balans qiymatiga nisbatan bozor qiymati|CSBR (Champions Oncology Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti XBiotech USA XBIT|Bozor kapitallashuvining balans qiymatiga nisbati CVM|Bozor kapitallashuvining balans qiymatiga nisbati ostherapies.com (OSTX)|Bozor qiymatining balans qiymatiga nisbati Radiopharm Theranostics RADX|ARTV - Kapitallashuvning sof aktivlarga nisbati|Adlai Nortye Limited - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Veru Corporation|Tempest Therapeutics (TPST) - Bozor qiymatining balans qiymatiga nisbati|Xilio Therapeutics - Balans qiymatiga nisbatan bozor qiymati|RENB (Renovaro Biosciences) - Bozor kapitallashuvining balans qiymatiga nisbati|Mural Bio (MURA) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati KAPA|Kapitallashuvning sof aktivlarga nisbati onkuretherapeutics.com OKUR|Bozor kapitallashuvining balans qiymatiga nisbati GDTC (CytoMed Therapeutics Limited)|Bozor kapitallashuvining balans qiymatiga nisbati Curis Inc. CRIS|APLM - Bozor qiymatining balans qiymatiga nisbati|THAR (Tharimmune Inc) - Kapitallashuvning balans qiymatiga nisbati|ADVB (advanbiomed.com) - Kapitallashuvning sof aktivlarga nisbati|Genprex Inc - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati Calidi Biotherapeutics Inc.|Bozor qiymatining balans qiymatiga koeffitsiyenti sunshinebiopharma.com SBFM|Bozor qiymatining balans qiymatiga nisbati Xenetic Biosciences (XBIO)|Salarius Pharmaceuticals Inc - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati PPBT (Purple Biotech Corp)|BGNE - Kapitallashuvning sof aktivlarga nisbati|CKPT - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Elevation Oncology Inc.|icadmed.com (ICAD) - Bozor qiymatining balans qiymatiga nisbati|IKNA (Ikena Oncology) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Notable Labs Inc.|Bozor qiymatining balans qiymatiga koeffitsiyenti Viracta VIRX|Bozor kapitallashuvining balans qiymatiga nisbati MOR|nayabiosciences.com (NAYA) - Bozor qiymatining xususiy kapitalga nisbati|Ascentage Pharma - Kapitallashuvning sof aktivlarga nisbati